🗞️ News - April 18, 2025

HealthMed Collaborates with Podimetrics to Support Diabetic Patients

HealthMed partners with Podimetrics to enhance diabetes care. 🩺 SmartMat technology helps prevent complications in high-risk patients. 👣

🌟 Stay Updated!
Join AI Health Hub to receive the latest insights in health and AI.

Partnership Overview

Podimetrics, a company focused on preventing serious complications for diabetes patients, has announced a partnership with HealthMed, a platform dedicated to employee health and wellness.

Integration of SmartMat Technology
  • HealthMed plans to incorporate Podimetrics’ SmartMat technology into its benefits offerings for large employers, hospitals, and municipalities.
  • HealthMed also provides wellness and mental health programs for employees.
SmartMat Functionality

The SmartMat is designed to:

  1. Measure foot temperature of high-risk diabetes patients.
  2. Detect early signs of inflammation that could lead to wounds, amputations, and diabetic foot ulcers.
Statements from Leadership

Dr. Jon Bloom, CEO of Podimetrics, expressed enthusiasm about the collaboration, stating:

“Our partnership with HealthMed is a strong collaboration, and we are excited to work together to support individuals with complex diabetes who are at the greatest risk for serious complications.”

Tracy Webster, founder of HealthMed, added:

“We look forward to the positive impact we can make on health outcomes and the overall cost of care.”

Recent Developments in the Industry

In March, Podimetrics partnered with Alivi Health to enhance podiatry benefits for health plans and payers using SmartMat technology. Additionally, in 2024, Podimetrics filed a patent infringement lawsuit against Bluedrop Medical, which was later dismissed after Podimetrics withdrew its claim.

Funding and Growth
  • In 2022, Podimetrics raised $45 million in a Series C funding round to expand product development and research.
  • In 2019, the company secured $13.4 million in Series B funding.
Other Notable Companies in Diabetes Care
  • Dexcom made a $75 million investment in Oura, enhancing data flow between their devices.
  • Glytec partnered with Roche to integrate its software with Roche’s blood glucose monitoring system.

These collaborations and innovations highlight the ongoing efforts to improve diabetes management and patient outcomes.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on whatsapp
WhatsApp

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.